Problem statement: Answer the multiple-choice question.
Query: Which drug exhibits a -18.071% human ether-à-go-go related gene (hERG) inhibition at a concentration of 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any additional words.
Options:
a. CSCC(C)N1CCC(CCC(=O)NC2CC2)CC1
b. CCC(C)[C@H](NC(=O)[C@@H]1CSC2c3ccccc3C(=O)N21)C(=O)NC1CCCC1
c. CC(C)CC(=O)Nc1ccc(C(=O)CN2CCC(C)CC2)cc1
d. CCc1ccc(NC(=O)C(=O)NNC(=O)c2ccc(OC)cc2)cc1
Answer: a. CSCC(C)N1CCC(CCC(=O)NC2CC2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CSCC(C)N1CCC(CCC(=O)NC2CC2)CC1
CSCC(C)N1CCC(CCC(=O)NC2CC2)CC1
N-cyclopropyl-3-[1-(1-methylsulfanylpropan-2-yl)piperidin-4-yl]propanamide